{
    "code": "12013690",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=12013690",
    "time": "2022-04-29 04:17:45",
    "許可證字號": "內衛藥製字第013690號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/12\/31",
    "發證\/登錄日期": "59\/10\/30",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY01201369000",
    "中文品名": "&quot;紐約&quot;新黴素錠",
    "英文品名": "NEOMYCIN SULFATE TABLETS &quot;N.Y.&quot;",
    "適應症": "腸外科痔瘡、肛門等手術前、腸道之消毒殺菌、細菌性痢疾、沙門氏菌、志賀氏菌、阿米巴、埃希氏大腸桿菌等所致傳染性腸炎、瀉痢",
    "劑型": "110錠劑",
    "包裝": "20.50.100.500等粒瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "NEOMYCIN SULFATE",
    "限制項目": "1R不得製造",
    "申請商名稱": "0201504200  人人化學製藥股份有限公司",
    "申請商地址": "桃園市中壢區南園二路３號",
    "主製造廠": [
        {
            "": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "30042000113 人用醫藥製劑，含胺基配醣體類抗生素者（含鏈黴素或其衍生物；其鹽類者除外）Medicaments, containing aminoglycosides (excluding streptomycins or their derivatives; salts thereof), for human use",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812100530",
            "成分名稱": "NEOMYCIN SULFATE",
            "含量描述": "",
            "含量": "500.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "120136900001.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=12013690&Seq=001&Type=9"
        }
    ]
}